p19ARF directly and differentially controls the functions of c-Myc independently of p53

Nature

Volumn 431, Issue 7009, 2004, Pages 712-717

  Qi, Ying ^a   Gregory, Mark A ^a   Li, Zhaoliang ^a   Brousal, Jeffrey P ^a   West, Kimberly ^a   Hann, Stephen R ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELLS; DISEASE CONTROL; GENES; GENETIC ENGINEERING; TUMORS;

CELL CYCLE; MOLECULAR MECHANISMS; TUMOR SUPPRESSORS; TUMORIGENESIS;

ONCOGENIC VIRUSES;

ARF PROTEIN; MYC PROTEIN; PROTEIN P19; PROTEIN P53; CDKN2A PROTEIN, MOUSE; PROTEIN P14ARF; PROTEIN P16INK4A;

MEDICINE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CARCINOGENESIS; CELL PROLIFERATION; CELL TRANSFORMATION; CONTROLLED STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; TRANSCRIPTION INITIATION; ANIMAL; CELL CYCLE; CELL DIVISION; CELL LINE; DRUG ANTAGONISM; GENE DELETION; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; HUMAN; METABOLISM; MOUSE; PROTEIN BINDING; RAT; SERODIAGNOSIS;

ANIMALIA;

ANIMALS; APOPTOSIS; CELL CYCLE; CELL DIVISION; CELL LINE; CELL TRANSFORMATION, NEOPLASTIC; CYCLIN-DEPENDENT KINASE INHIBITOR P16; GENE DELETION; GENE EXPRESSION REGULATION; HUMANS; MICE; PRECIPITIN TESTS; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS C-MYC; RATS; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEIN P14ARF; TUMOR SUPPRESSOR PROTEIN P53;

EID: 6044254972     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/nature02958     Document Type: Article

References (30)

1. Oster, S. K., Ho, C. S., Soucie, E. L. & Penn, L. Z. The myc oncogene: MarvelouslY complex. Adv. Cancer Res. 84, 81-154 (2002).
2. Sherr, C. J. The INK4a/ARF network in tumour suppression. Nature Rev. Mol. Cell Biol. 2, 731-737 (2001).
3. Pelengaris, S., Khan, M. & Evan, G. c-MYC: More than just a matter of life and death. Nature Rev. Cancer 2, 764-776 (2002).
4. Zindy, F. et al. Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization. Genes Dev. 12, 2424-2433 (1998).
5. Weber, J. D., Taylor, L. J., Roussel, M. F., Sherr, C. J. & Bar-Sagi, D. Nucleolar Arf sequesters Mdm2 and activates p53. Nature Cell Biol. 1, 20-26 (1999).
6. Datta, A. et al. Myc-ARF interaction inhibits the functions of Myc. J. Biol. Chem. 279, 36698-36707 (2004).
7. Grandori, C. & Eisenman, R. N. Myc target genes. Trends Biochem. Sci. 22, 177-181 (1997).
8. Greenberg, R. A. et al. Telomerase reverse transcriptase gene is a direct target of c-Myc but is not functionally equivalent in cellular transformation. Oncogene 18, 1219-1226 (1999).
9. Wu, K. J. et al. Direct activation of TERT transcription by c-MYC. Nature Genet. 21, 220-224 (1999).
10. O'Hagan, R. C. et al. Myc-enhanced expression of Cul1 promotes ubiquitin-dependent proteolysis and cell cycle progression. Genes Dev. 14, 2185-2191 (2000).
11. Marhin, W. W., Chen, S., Facchini, L. M., Fornace, A. J. Jr & Penn, L. Z. Myc represses the growth arrest gene gadd45. Oncogene 14, 2825-2834 (1997).
12. Oster, S. K. et al. Myc is an essential negative regulator of platelet-derived growth factor beta receptor expression. Mol. Cell Biol. 20, 6768-6778 (2000).
13. Xiao, Q. et al. Transactivation-defective c-MycS retains the ability to regulate proliferation and apoptosis. Genes Dev. 12, 3803-3808 (1998).
14. Evan, G. I. et al. Induction of apoptosis in fibroblasts by c-myc protein. Cell 69, 119-128 (1992).
15. Harrington, E. A., Bennett, M. R., Fanidi, A. & Evan, G. I. c-Myc-induced apoptosis in fibroblasts is inhibited by specific cytokines. EMBO J. 13, 3286-3295 (1994).
16. Lenahan, M. K. & Ozer, H. L. Induction of c-myc mediated apoptosis in SV40-transformed rat fibroblasts. Oncogene 12, 1847-1854 (1996).
17. Amanullah, A., Liebermann, D. A. & Hoffman, B. p53-independent apoptosis associated with c-Myc-mediated block in myeloid cell differentiation. Oncogene 19, 2967-2977 (2000).
18. Fukasawa, K., Wiener, F., Vande Woude, G. F. & Mai, S. Genomic instability and apoptosis are frequent in p53 deficient young mice. Oncogene 15, 1295-1302 (1997).
19. Korgaonkar, C., Zhao, L., Modestou, M. & Quelle, D. E. ARF function does not require p53 stabilization or Mdm2 relocalization. Mol. Cell. Biol. 22, 196-206 (2002).
20. Sakamuro, D. et al. c-Myc induces apoptosis in epithelial cells by both p53-dependent and p53-independent mechanisms. Oncogene 11, 2411-2418 (1995).
21. Trudel, M. et al. c-myc-induced apoptosis in polycystic kidney disease is Bcl-2 and p53 independent. J. Exp. Med. 186, 1873-1884 (1997).
22. Tsuji, K. et al. p53-independent apoptosis is induced by the p19ARF tumor suppressor. Biochem. Biophys. Res. Commun. 295, 621-629 (2002).
23. Weber, J. D. et al. p53-independent functions of the p19(ARF) tumor suppressor. Genes Dev. 14, 2358-2365 (2000).
24. Jacobs, J. J. et al. Bmi-1 collaborates with c-Myc in tumorigenesis by inhibiting c-Myc-induced apoptosis via INK4a/ARF. Genes Dev. 13, 2678-2690 (1999).
25. Eischen, C. M., Weber, J. D., Roussel, M. F., Sherr, C. J. & Cleveland, J. L. Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis. Genes Dev. 13, 2658-2669 (1999).
26. Haviernik, P., Schmidt, M., Hu, X. & Wolff, L. Consistent inactivation of p19(Arf) but not p15(Ink4b) in murine myeloid cells transformed in vivo by deregulated c-Myc. Oncogene 22, 1600-1610 (2003).
27. Oster, S. K., Mao, D. Y., Kennedy, J. & Penn, L. Z. Functional analysis of the N-terminal domain of the Myc oncoprotein. Oncogene 22, 1998-2010 (2003).
28. Conzen, S. D. et al. Induction of cell cycle progression and acceleration of apoptosis are two separable functions of c-Myc: transrepression correlates with acceleration of apoptosis. Mol. Cell. Biol. 20, 6008-6018 (2000).
29. Soucek, L. et al. Omomyc, a potential Myc dominant negative, enhances Myc-induced apoptosis. Cancer Res. 62, 3507-3510 (2002).
30. Gregory, M. A., Qi, Y. & Hann, S. R. Phosphorylation by glycogen synthase kinase-3 controls c-myc proteolysis and subnuclear localization. J. Biol. Chem. 278, 51606-51612 (2003).